Home › Malattia di Crohn › Georgia
Studi clinici su Malattia di Crohn nello stato di Georgia
22 studi su Malattia di Crohn cercano partecipanti presso sedi nello stato di Georgia.
Città nello stato di Georgia
Testo ufficiale dello studio (inglese)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Morehouse School Of Medicine ( Site 5071), Atlanta
- Gastroenterology Associates of Central Georgia ( Site 5048), Macon
In reclutamentoFase 3
Età da 16 a 80 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Associates of Central Georgia /ID# 280464, Macon
- Gastroenterology Consultants - Roswell /ID# 281235, Roswell
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Digestive Healthcare of Georgia, Atlanta
- AGA GA Research LLC, Atlanta
In reclutamentoFase 4
Età da 18 a 80 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06581328A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Emory University, Atlanta
- Children's Center for Digestive Health Care, Atlanta
In reclutamentoFase 3
Età da 2 a 17 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Gastroenterology Associates of Central Georgia /ID# 265547, Macon
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Morehouse School of Medicine, Atlanta
- Gastroenterology Associates of Central GA, Macon
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Emory University, Atlanta
- Children's Center for Digestive Health Care, Atlanta
- Gastroenterolgy Associates of Central GA, Macon
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Emory University, Atlanta
- Children's Center for Digestive Healthcare, Atlanta
In reclutamentoFase 3
Età 3 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Emory University Hospital, The Emory Clinic, Atlanta
- Atlanta Center For Gastroenterology, P.C., Decatur
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06233461An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Atlanta Gastroenterology Associates-Site Number: 8400109, Atlanta
- M3 Wake Research - Atlanta-Site Number: 8400028, Sandy Springs
- EBGS Clinical Research Center, LLC-Site Number: 8400037, Snellville
- e altri 1
In reclutamentoFase 3
Età da 16 a 80 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07184931A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Atlanta Gastroenterology Specialists, PC, Atlanta
- Atlanta Gastroenterology Associates (Part of United Digestive), Atlanta
In reclutamentoFase 2
Età da 18 a 85 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Emory University School of Medicine, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
In reclutamentoFase 3
Età da 2 a 19 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Gastroenterology Consultants, P.C., Roswell
In reclutamentoFase 4
Età da 18 a 70 · Tutti i sessi · Aggiornato il 9 set 2026 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Atlanta Gastroenterology Specialists, Suwanee
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT07577843A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Emory University, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
In reclutamentoFase 3
Età da 2 a 17 · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT05509777Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Emory University, Atlanta
In reclutamentoFase 4
Età da 6 a 17 · Tutti i sessi · Aggiornato il 27 mag 2026 · NCT05781152A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Center For Digestive Healthcare, Atlanta
In reclutamentoFase 3
Età 2 e oltre · Tutti i sessi · Aggiornato il 7 mag 2026 · NCT05442567A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Childrens Center For Digestive Healthcare, Atlanta
In reclutamentoFase 3
Età da 2 a 17 · Tutti i sessi · Aggiornato il 5 mag 2026 · NCT04779320A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400019, Marietta
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 27 mar 2026 · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Atlanta
- Mirador Therapeutics Selected Site, Snellville
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT07113522Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.